Title |
Imatinib activity on Schistosoma mansoni
|
---|---|
Published in |
Memórias do Instituto Oswaldo Cruz, November 2013
|
DOI | 10.1590/0074-0276130207 |
Pubmed ID | |
Authors |
Naftale Katz, Flávia Fernanda Bubulo Couto, Neusa Araújo |
Abstract |
Imatinib, a drug used for treatment of human chronic myeloid leukaemia, due to its activity against protein kinases, has been also evaluated in vitro against Schistosoma mansoni showing high schistosomicidal activity. In the present experiments imatinib activity in vitro was confirmed at the doses of 25 µM, 50 µM and 100 µM. The first drug activity observed with the lower dose was interruption of egg-laying and with the higher dosages was the death of the worms. In mice infected with S. mansoni no activity was found even with 1,000 mg/kg/day, 500 mg/kg/day, single oral dose or when administered for three consecutive days. This is another example of the difference of results related to in vitro and in vivo trials using S. mansoni worms. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 5 | 16% |
Unknown | 27 | 84% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 25% |
Student > Master | 7 | 22% |
Student > Ph. D. Student | 5 | 16% |
Professor | 2 | 6% |
Student > Doctoral Student | 2 | 6% |
Other | 6 | 19% |
Unknown | 2 | 6% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 11 | 34% |
Biochemistry, Genetics and Molecular Biology | 6 | 19% |
Immunology and Microbiology | 3 | 9% |
Chemistry | 3 | 9% |
Medicine and Dentistry | 3 | 9% |
Other | 3 | 9% |
Unknown | 3 | 9% |